Skip to main content

Peer Review reports

From: Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression

Original Submission
17 May 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
26 Feb 2015 Editorially accepted
13 Mar 2015 Article published 10.1186/s12885-015-1139-7

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us